The primary objective of this study is to determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease than a standard disease management program.

To determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease.

Inclusion Criteria

• Between 18 and 64 years of age as of January 1, 2008
• Diagnosis of diabetes mellitus (listed ICD-9-CM diagnosis code on two or more outpatient claims, or on one or more inpatient admissions or emergency room claims in the most recent 12-month period)
• Continuously enrolled in a health plan with pharmacy and medical benefits for the most recent 12-month period or with one period of non-enrollment up to only 30 days
• Able to provide written informed consent for study participation

Exclusion Criteria

• Advanced renal disease (one or more claims in the most recent 12-month period) as defined by a claim for nephropathy or creatinine greater than 2.5 mg/dl
• Selected cancers (one or more claims in the most recent 12-month period)
• HIV/AIDS (one or more claims in the most recent 12-month period)
• Heart, liver, kidney, or multiple organ transplant (one or more claims in the most recent 12-month period)
• Cirrhosis of the liver (one or more claims in the most recent 12-month period)
• Current participation in another LifeScan study or other diabetes-related clinical trials
• Medicare is primary source of insurance coverage
• Unable to understand written and spoken English